Document is current

Any future updates will be listed below

A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer’s disease

Crossref DOI link: https://doi.org/10.1186/s13195-015-0119-0

Published Online: 2015-04-14

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark